Expression of the nerve growth factor receptors TrkA and p75 in malignant mesothelioma

Ben Davidson1, Reuven Reich, Philip Lazarovici

  • 1Department of Pathology, The Norwegian Radium Hospital, Montebello N-0310 Oslo, University of Oslo, Oslo, Norway. bend@ulrik.uio.no

Insights

Nerve growth factor (NGF) receptors p75 and TrkA were studied in malignant mesothelioma (MM). TrkA receptor expression was frequent, especially in peritoneal MM, suggesting its role in tumor progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Malignant mesothelioma (MM) is an aggressive cancer.
  • Nerve growth factor (NGF) receptors, including p75 and TrkA, are implicated in cancer cell growth and survival.

Purpose of the Study:

  • To investigate the expression of p75 and activated TrkA receptors in malignant mesothelioma.
  • To determine if receptor expression differs between pleural and peritoneal MM, and between solid lesions and effusions.

Main Methods:

  • Immunohistochemistry was used to analyze p75 and phospho-TrkA (p-TrkA) expression in 81 MM specimens (biopsies and effusions).
  • Immunoblotting was performed on six effusions to confirm p-TrkA expression.

Main Results:

  • Activated TrkA (p-TrkA) membrane expression was frequent (81%), while p75 expression was less common (32%).
  • p-TrkA expression was significantly higher in peritoneal MM compared to pleural MM (P = 0.014).
  • p-TrkA expression was marginally higher in effusions, whereas p75 expression was higher in solid lesions.

Conclusions:

  • Frequent p-TrkA and lower p75 expression in MM align with the tumor's aggressive nature.
  • Enhanced p-TrkA expression in peritoneal MM and effusions suggests a significant role in disease biology and progression.

Related Concept Videos

Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...